Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · IEX Real-Time Price · USD
1.060
+0.010 (0.95%)
May 3, 2024, 4:00 PM EDT - Market closed
Lineage Cell Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$6.50
Upside
+513.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +560.38% | Mar 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +560.38% | Feb 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +466.04% | Feb 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +560.38% | Aug 11, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +466.04% | Jul 25, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +560.38% | Jul 24, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +560.38% | May 12, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +560.38% | Apr 26, 2023 |
| Baird | Baird | Buy Initiates $5 | Buy | Initiates | $5 | +371.70% | Nov 2, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +277.36% | Jun 14, 2022 |
| Noble Capital Markets | Noble Capital Markets | Buy Initiates $8 | Buy | Initiates | $8 | +654.72% | Aug 19, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 31, 2021 |